← 홈

CGT

1,235개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologicstaleAffiliated Hospital to Academy …Phase 2

Anti-CD22-CAR-transduced T cells (Anti-CD22-CAR-transduced T cells)

Leukemia; Lymphoma · CD22

#CD22#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleSouthwest Hospital, ChinaPhase 2

Anti-CD30-CAR-transduced T cells (Anti-CD30-CAR-transduced T cells)

Leukemia; Lymphoma · CD30

#CD30#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

Anti-CD5 CAR NK cells (Anti-CD5 CAR NK cells)

T-ALL/Lymphoma · T-ALL/Lymphoma

#T-ALLLymphoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUTC Therapeutics Inc.Phase 1

Anti-CD70 CAR-T cells (Anti-CD70 CAR-T cells)

CD70-positive Advanced Urologic Neoplasms · CD70-positive Advanced Urologic Neoplasm

#CD70-positiveAdvancedUrologicNeo#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Pudong HospitalPhase 1

Anti-CDH17 CAR-T cells (Anti-CDH17 CAR-T cells)

CDH17-positive Advanced Malignant Solid Tumors · CDH17-positive Advanced Malignant Solid

#CDH17-positiveAdvancedMalignantS#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleShanghai Cell Therapy Research …Phase 2

Anti-CTLA-4/PD-1 expressing MUC1-CAR-T (Anti-CTLA-4/PD-1 expressing MUC1-CAR-T)

Advanced Solid Tumor · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

Anti-Cluster of Differentiation (CD, Anti-Cluster of Differentiation, Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR))

ALL; B Cell Lymphoma · ALL

#ALL#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleOhio State University Comprehen…Phase 1

Anti-GARP Chimeric Antigen Receptor-T Cells (Anti-GARP Chimeric Antigen Receptor-T Cells)

Recurrent Malignant Glioma; Recurrent WHO Grade 3 Glioma · Recurrent Malignant Glioma

#RecurrentMalignantGlioma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

Anti-GD2-CAR engineered T cells (Anti-GD2-CAR engineered T cells)

Sarcoma; Osteosarcoma · GD2

#GD2#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstale920th Hospital of Joint Logisti…Phase 2

Anti-GPRC5D CAR-T cells infusion (Anti-GPRC5D CAR-T cells infusion)

Multiple Myeloma in Relapse; Multiple Myeloma, Refractory · GPRC5D

#GPRC5D#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
CGTBiologicstaleZhi YangPhase 2

Anti-HER2 CAR-T (Anti-HER2 CAR-T)

Breast Cancer; Ovarian Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleUTC Therapeutics Inc.Preclinical

Anti-HER2 CAR-T cells (Anti-HER2 CAR-T cells)

HER2-positive Advanced Malignant Solid Tumors · HER2

#HER2#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of Southern Californ…Phase 1

Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes (Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes)

Triple Negative Breast Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-KRAS G12V mTCR PBL (Anti-KRAS G12V mTCR PBL)

Pancreatic Cancer; Gastric Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

Anti-LILRA6 CAR-T cells (Anti-LILRA6 CAR-T cells)

Refractory Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSouthwest Hospital, ChinaPhase 2

Anti-LeY-CAR-transduced T cells (Anti-LeY-CAR-transduced T cells)

Myeloid Malignancies · Myeloid Malignancies

#MyeloidMalignancies#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-MAGE-A3 human leukocyte antigen serotype within HLA-A A serotype group (HLA-A* 01, Anti-MAGE-A3 human leukocyte antigen serotype within HLA-A A serotype group, Anti-MAGE-A3 human leukocyte antigen serotype within HLA-A A serotype group (HLA-A* 01)-restricted T-cell receptor (TCR))

Breast Cancer; Cervical Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 1상태 DISCONTINUED
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-MAGE-A3-DP4 T Cell Receptor (TCR, Anti-MAGE-A3-DP4 T Cell Receptor, Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL))

Cervical Cancer; Renal Cancer · Cervical Cancer

#CervicalCancer#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 4%임상시험 1상태 ACTIVE
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-NY ESO-1 T cell receptor (TCR, Anti-NY ESO-1 T cell receptor, Anti-NY ESO-1 T cell receptor (TCR) cluster of differentiation 62L (CD62L)+ cells)

Metastatic Cancer; Metastatic Melanoma · Metastatic Cancer

#MetastaticCancer#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 4%임상시험 1상태 DISCONTINUED
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-NY ESO-1 mTCR PBL (Anti-NY ESO-1 mTCR PBL)

Melanoma; Meningioma · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE

24 / 62 페이지

← 이전다음 →